In Treatment of Epilepsy/Seizures Levera Rtu 1000 Infusion belongs to a group of medicines called anticonvulsants (or anti-epileptics). It works by slowing down electrical signals in the brain which cause seizures (fits). This medicine can be used to control various types of seizures—myoclonic, partial-onset, and primary generalized tonic-clonic (or grand mal). It can also help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. The medicine can allow you to do some activities that you would otherwise be forbidden or scared to do (such as swimming and driving). It can take a few weeks for this medicine to work (because the dose has to be increased slowly) and during this time you may still have seizures. You should continue taking it even if you feel well and are not having any seizures. Missing doses may trigger a seizure. Do not stop using this medicine until your doctor advises you.
It is unsafe to consume alcohol with Levera Rtu 1000 Infusion.
Levera Rtu 1000 Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Levera Rtu 1000 Infusion is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Monitor the baby for sleepiness and adequate weight gain.
Levera Rtu 1000 Infusion may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Levera Rtu 1000 Infusion should be used with caution in patients with kidney disease. Dose adjustment of Levera Rtu 1000 Infusion may be needed. Please consult your doctor.
Levera Rtu 1000 Infusion is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Levera Rtu 1000 Infusion may not be needed in these patients. Please consult your doctor. However, a lower dose may be advised in patients with severe liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: UCB India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Radix Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: USV Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Molekule India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr. Edwin Lab || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Trireme Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)